| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Prometheus Biosciences Inc (NASDAQ: RXDX)
RXDX Technical Analysis
5
| As on 9th Jun 2023 RXDX STOCK Price closed @ 198.99 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 40.04 & Strong Buy for SHORT-TERM with Stoploss of 37.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RXDXSTOCK Price
| Open | 199.00 | Change | Price | % |
| High | 199.10 | 1 Day | 0.01 | 0.01 |
| Low | 198.91 | 1 Week | 0.39 | 0.20 |
| Close | 198.99 | 1 Month | 4.84 | 2.49 |
| Volume | 1002667 | 1 Year | 169.18 | 567.53 |
| 52 Week High 198.85 | 52 Week Low 22.39 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RXDX Daily Charts |
RXDX Intraday Charts |
Whats New @ Bazaartrend |
RXDX Free Analysis |
|
|
RXDX Important Levels Intraday
| RESISTANCE | 199.36 |
| RESISTANCE | 199.24 |
| RESISTANCE | 199.17 |
| RESISTANCE | 199.09 |
| SUPPORT | 198.89 |
| SUPPORT | 198.81 |
| SUPPORT | 198.74 |
| SUPPORT | 198.62 |
RXDX Forecast April 2024
| 4th UP Forecast | 227.26 |
| 3rd UP Forecast | 218.19 |
| 2nd UP Forecast | 212.59 |
| 1st UP Forecast | 206.99 |
| 1st DOWN Forecast | 190.99 |
| 2nd DOWN Forecast | 185.39 |
| 3rd DOWN Forecast | 179.79 |
| 4th DOWN Forecast | 170.72 |
RXDX Weekly Forecast
| 4th UP Forecast | 210.71 |
| 3rd UP Forecast | 206.95 |
| 2nd UP Forecast | 204.63 |
| 1st UP Forecast | 202.30 |
| 1st DOWN Forecast | 195.68 |
| 2nd DOWN Forecast | 193.35 |
| 3rd DOWN Forecast | 191.03 |
| 4th DOWN Forecast | 187.27 |
RXDX Forecast2024
| 4th UP Forecast | 541.42 |
| 3rd UP Forecast | 431.6 |
| 2nd UP Forecast | 363.72 |
| 1st UP Forecast | 295.84 |
| 1st DOWN Forecast | 102.14 |
| 2nd DOWN Forecast | 34.26 |
| 3rd DOWN Forecast | -33.62 |
| 4th DOWN Forecast | -143.44 |
Prometheus Biosciences Inc ( NASDAQ USA Symbol : RXDX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RXDX Business Profile
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of precision therapeutics and companion diagnostics products for the treatment and diagnosis of inflammatory bowel diseases (IBD). Its products include PRA023, a Phase I clinical trial IgG1 humanized monoclonal antibody (mAb); PR600, an anti- tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1800, anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. The company has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. Prometheus Biosciences, Inc. was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. The company was founded in 2016 and is based in San Diego, California. Address: 9410 Carroll Park Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service